Publications by authors named "Pedro Franco-Fuquen"
Article Synopsis
- - The HL7 organization created a set of 45 sensitive data categories to help implement electronic consent technology, enabling patients to control the sharing of their sensitive medical records.
- - A study involving twelve physicians led to revisions of 21 of these categories, including the addition of new categories and the modification of existing definitions to promote clearer communication and inclusivity.
- - Future updates to the HL7 categories should integrate physicians' insights, validate them with patient data, and prioritize patient perspectives for a more patient-centered approach.
Chimeric Antigen Receptor (CAR) T-cell therapies have emerged as an effective and potentially curative immunotherapy for patients with relapsed or refractory malignancies. Treatment with CD19 CAR T-cells has shown unprecedented results in hematological malignancies, including heavily refractory leukemia, lymphoma, and myeloma cases. Despite these encouraging results, CAR T-cell therapy faces limitations, including the lack of long-term responses in nearly 50-70% of the treated patients and low efficacy in solid tumors.
View Article and Find Full Text PDF